Choi Jae Sue, Han Yu Ran, Byeon Jeong Su, Choung Se-Young, Sohn Hee Sook, Jung Hyun Ah
Department of Food Science and Nutrition, Pukyong National University, Busan, Korea.
College of Pharmacy, Kyeong Hee University, Seoul, Korea.
J Pharm Pharmacol. 2015 Aug;67(8):1170-8. doi: 10.1111/jphp.12404. Epub 2015 Mar 13.
Fucosterol is the primary sterol found in brown algae. Recently, considerable interest has been generated regarding fucosterol due to its potential antioxidant, anti-inflammatory and antidiabetic effects. The aim of this study was to investigate the protective effects of fucosterol on tert-butyl hydroperoxide (t-BHP)- and tacrine-induced oxidative stress in HepG2 cells.
Fucosterol by itself exhibited no cytotoxicity at concentrations below 100 μm by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. The increased intracellular reactive oxygen species (ROS) and decreased glutathione levels observed in t-BHP- and tacrine-treated HepG2 cells were ameliorated by fucosterol pretreatment, indicating that the protective effects of fucosterol are mediated by the induction of cellular defence mechanisms against oxidative stress. Moreover, elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in tacrine-treated mice were significantly reduced after oral administration of fucosterol.
The hepatoprotective effects of fucosterol may occur via an increase in the hepatic level of glutathione and a decrease in ROS production, thereby preventing hepatic damage and the resultant increases in ALT and AST activity.
These results suggest that fucosterol may be an effective hepatoprotective agent that could be useful for preventive therapies against oxidative stress-related hepatotoxicity.
岩藻甾醇是褐藻中发现的主要甾醇。最近,由于其潜在的抗氧化、抗炎和抗糖尿病作用,岩藻甾醇引起了人们的极大兴趣。本研究的目的是探讨岩藻甾醇对叔丁基过氧化氢(t-BHP)和他克林诱导的HepG2细胞氧化应激的保护作用。
通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法检测,岩藻甾醇在浓度低于100μm时本身无细胞毒性。岩藻甾醇预处理可改善t-BHP和他克林处理的HepG2细胞中观察到的细胞内活性氧(ROS)增加和谷胱甘肽水平降低,表明岩藻甾醇的保护作用是通过诱导细胞抗氧化应激防御机制介导的。此外,口服岩藻甾醇后,他克林处理的小鼠中升高的丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)水平显著降低。
岩藻甾醇的肝脏保护作用可能通过增加肝脏中谷胱甘肽水平和减少ROS产生而发生,从而预防肝脏损伤以及由此导致的ALT和AST活性增加。
这些结果表明,岩藻甾醇可能是一种有效的肝脏保护剂,可用于预防与氧化应激相关的肝毒性的治疗。